Form 4: Fulgent Genetics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Hanlin Gao, Chief Scientific Officer of Fulgent Genetics, Inc., reported a transaction in 1,645 shares of common stock on July 26, 2026.
Summary
- Tax/exercise-price withholding: disposed of 1,645 Common Stock at $19.67 ($32,357) on July 26, 2026; holds 988,729 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Hanlin Gao — Officer (Chief Scientific Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-26 | Tax/exercise-price withholding | Common Stock | 1,645 | $20 | $32.4K | 988,729 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-26 | Tax/exercise-price withholding (1,645 shares) |
Keywords
insider transaction, Form 4, FLGT, Fulgent Genetics, Inc., neutral, Hanlin Gao
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.